Adipotide is a complex, hard-to-synthesize experimental compound. Making it takes expertise \u2014 and technology. The quality of your research stands and falls with its structural integrity, so you need a research and scientific company that gets it right. That\u2019s CellPeptides. We\u2019re based in EUand our lab is WHO\/GMP and ISO 9001:2015 certified.\u00a0<\/span><\/p>\n When you order from us, you benefit from:<\/span><\/p>\n Your Adipotide research is nothing short of groundbreaking. Got any questions? Want to run your study design by a team that understands how exciting it is? We\u2019re here, and our support team is pretty knowledgeable. (We make the compound that will go on to power your scientific discoveries, after all!)<\/span><\/p>\n It\u2019s not elegant \u2014 but it is effective. Proof-of-concept studies in obese mice and later rhesus monkeys demonstrated impressive weight loss (11 percent in just 30 days for the monkeys!), serious drops in abdominal circumference, and improved insulin sensitivity.\u00a0<\/span><\/p>\n Adipotide\u2019s mechanism of action is nothing like Semaglutide\u2019s or Tirzepatide\u2019s. It doesn\u2019t work by keeping appetite down or speeding metabolic processes up. Instead, it starves fat cells \u2014 specifically, white adipose tissue of the nutrients and oxygen they need to keep existing.\u00a0<\/span><\/p>\n It\u2019s a two-stage process. First, Adipotide binds to the protein prohibitin. The cells that line the blood vessels responsible for supplying fat tissue are covered in it \u2014 but other blood vessels not so much. Then, it goes to war with the mitochondrial membranes, essentially forcing those blood vessels into a self-destruct sequence.\u00a0<\/span><\/p>\n Fat cells, now robbed of their lifeblood, get reabsorbed. Never to be seen again.\u00a0<\/span><\/p>\n No natural peptide has the same function. Adipotide wasn\u2019t copy\/pasted from Mother Nature. It was engineered to prune blood vessels in a very targeted way. Amazing? We certainly think so. The research potential is obvious. It is immense. And it\u2019s exciting, all the more so because Adipotide studies are still in their early phases.\u00a0<\/span><\/p>\n The mechanism of action isn\u2019t the only impressively interesting thing about Adipotide. Observed outcomes in early models are just as worth reading about. The existing body of science has taken Adipotide out of the conceptual, hypothetical realm into the domain of hard science \u2014 with amazingly quick results in animal models. Curious? Wait until you hear about the findings.\u00a0<\/span><\/p>\n That\u2019s the dangerous kind, the kind that appears all over the body \u2014 as bone marrow fat, visceral fat, and subcutaneous fat. Adipotide was designed to destroy it, and early research shows it does exactly that. When the compound declares war on the vasculature that supplies fat stores, it takes them out.\u00a0<\/span><\/p>\n The first Adipotide studies were done on obese mice. Those mice lost weight. Quickly. But they also enjoyed improved health outcomes as the secondary effects of obesity (the lingering metabolic effects) were reversed. Research then continued with rhesus monkeys. They also lost weight. Eleven percent of their starting body weight in under a month, to be precise. [1<\/a>, 2<\/a>]<\/span><\/p>\n The research showed that zapping white adipose tissue directly leads to impressive weight loss results, while demonstrating the power of Adipotide in action. The results weren\u2019t cosmetic. We\u2019re not talking about \u201cwater weight\u201d here \u2014 the mechanism by which fad diets usually get such fast results that wear off just as quickly. Adipotide tackles obesity at the root.\u00a0<\/span><\/p>\n Oh, we\u2019re still missing something huge that bears spelling out explicitly, because it\u2019s almost unbelievable otherwise. The animal studies done so far led to these dramatic weight loss results\u2026 <\/span>without a caloric reduction<\/span><\/i>.\u00a0<\/span><\/p>\n That\u2019s not a sustainable model for future obesity treatment in humans, to be sure, but it shows just how effective Adipotide can be.\u00a0<\/span><\/p>\n Several peptides now commonly used to treat obesity, notably Semaglutide and Tirzepatide, were first developed as next-gen diabetes treatments. There\u2019s some role reversal going on with Adipotide. American researchers explicitly designed it to kill fat by cutting off its blood supply. Adipotide also, however, has extra benefits.\u00a0<\/span><\/p>\n The landmark rhesus monkey study found that the test subjects had improved insulin resistance and metabolic function. That\u2019s a direct result of reduced white adipose tissue. Losing inflammatory visceral fat restores insulin function \u2014 and from there, the path to better health outcomes is very direct. [3<\/a>, 4<\/a>]<\/span><\/p>\n Obesity treatment is important (2.5 billion people across the globe suffer from this serious metabolic disorder), but these findings suggest potential future applications for Adipotide even beyond it. Future metabolic syndrome and type 2 diabetes studies are very likely to zoom in on the potential of Adipotide.\u00a0<\/span><\/p>\n Who would research an extraordinarily aggressive peptidomimetic with a completely new mechanism of action \u2014 purpose-built around two natural processes, angiogenesis and apoptosis? Researchers at the cutting edge, of course. Those looking for different answers to very old questions.\u00a0<\/span><\/p>\n Advanced metabolic and obesity research is, of course, grabbing all the attention. If you\u2019re the kind of researcher who asks what it takes to treat obesity with surgical precision \u2014 but without bariatric surgery? Adipotide should absolutely be on your radar.\u00a0<\/span><\/p>\n Other kinds of research are taking place, too. Adipotide is interesting to researchers investigating blood vessel development in in vitro settings, oncology studies (tumors depend on blood supply, too), and the way Adipotide and more established weight loss peptides might interact and lead to even more dramatic results.\u00a0<\/span><\/p>\n Regardless of your area of study, one thing is clear. Your research depends on pharmaceutical-grade Adipotide with the potential to replicate the results of the exciting studies done to date. CellPeptides provides the sequence you need for radical breakthroughs, and we hope your study begins with us.\u00a0<\/span><\/p>\n Your Adipotide study design should always start with a thorough review of existing literature and known side effect profile to help you determine the best dosing protocol for your specific model \u2014 and strictly follow ethical standards.\u00a0<\/span><\/p>\n The important studies we looked at earlier calculate dosing based on the body weight of the model, and 0.1 to 3.0 mg per kilogram of body weight is a frequently cited range. Treatment periods have ranged from several days to a full month in these study designs. The method tends to focus on daily dosing. Adipotide has a complex, targeted mechanism that calls for careful ongoing monitoring in in vivo applications.\u00a0<\/span><\/p>\n CellPeptides provides Adipotide in lyophilized form. Researchers prepare it for multi-dose applications by reconstituting the compound with bacteriostatic water (never tap or demineralized water!). Angle the syringe at the vial wall and inject the appropriate amount for your desired concentration slowly. Then, roll or swirl until clear. No shaking! (Patience is a virtue \u2014 you\u2019ll get there eventually.) Once done, Adipotide can be used for multi-dose applications if stored between 2 and 8 \u00b0C consistently for up to 30-60 days.\u00a0<\/span><\/p>\n Have a technical question about preparing Adipotide for research? Run your research design questions by CellPeptides if you want a second pair of eyes from the team that synthesizes your compounds.<\/span><\/p>\n Also feel free to use our free peptide calculator<\/a> showing how much to draw based on how much BAC water was added.<\/p>\n What research has been done on Adipotide so far?<\/b><\/p>\n Mostly preclinical, but undeniably impressive. Obese rodents and primate studies proved that Adipotide has the potential to kill fat cells by starving them of their blood supply in practice. These results coincided with dramatic weight loss and metabolic improvements. They\u2019re a good foundation to start further research with.<\/span><\/p>\n Do insights into the long-term safety profile of Adipotide exist?\u00a0<\/b><\/p>\n Because Adipotide remains in its early research phases, with new studies still regularly emerging, long-term safety data is not yet available. Preclinical studies assessed the short-term results of Adipotide. Researchers contemplating longer studies need to design their research with strict safety and ethical monitoring.<\/span><\/p>\n What are the future prospects for clinical use?<\/b><\/p>\n It will take time for Adipotide to move past the preclinical stage, but the potential future applications are squarely in obesity treatment \u2014 with metabolic syndrome and type 2 diabetes as additional potential use cases. We\u2019re not there yet, though!\u00a0<\/span><\/p>\n Adipotide (tako\u0111er poznat kao apoptozni peptid ciljan na masno tkivo ili FTPP)<\/strong> koristi potpuno druga\u010diju strategiju u borbi protiv tvrdokorne masno\u0107e (zaboravite na suzbijanje apetita ili ubrzavanje metaboli\u010dkih procesa) \u2014 koristi ciljanu uskratsku metodu. Ovaj peptidomimetik prepoznaje, cilja i uni\u0161tava potporni sustav koji odr\u017eava bijelo masno tkivo. Njegovu opskrbu krvlju.\u00a0<\/span><\/p>\n Ovaj uzbudljivi eksperimentalni spoj precizno je konstruiran u SAD-u kako bi prepoznao specifi\u010dan marker, prohibitin, na endotelnim stanicama krvnih \u017eila koje hrane masne naslage (dok druge krvne \u017eile ostavlja na miru). A onda? Adipotid kre\u0107e u napad. Probija mitohondrijske membrane kako bi u\u010dinio ne\u0161to \u0161to su mnogi drugi peptidni spojevi dizajnirani sprije\u010diti<\/strong>. Potaknite apoptozu. Lokalizirana, ciljana programirana smrt stanica.<\/span><\/p>\n Agresivno? I te kako. Rani istra\u017eiva\u010dki radovi pokazuju da je i u\u010dinkovit. Adipotid nudi jedan od najkreativnijih odgovora na pretilost i metaboli\u010dke poreme\u0107aje, i nimalo ne \u010dudi \u0161to istra\u017eiva\u010di staju u red kako bi prou\u010davali njegove u\u010dinke.<\/span><\/p>","protected":false},"featured_media":986,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[52,45,51],"product_tag":[],"class_list":["post-823","product","type-product","status-publish","has-post-thumbnail","product_cat-anti-inflammatory-response-research-peptides","product_cat-peptides-for-fat-metabolism-research","product_cat-peptides-for-weight-management-research","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n\n
How Does Adipotide Work?<\/b><\/h2>\n
Early Adipotide Research in Weight Loss and Insulin Sensitivity: The Evidence So Far<\/b><\/h2>\n
Adipotide Leads to a Dramatic Reduction in White Adipose Tissue<\/b><\/h3>\n
Improved Insulin Sensitivity in Adipotide Research \u2014 The Secondary Benefit<\/b><\/h3>\n
Who Might Consider Researching Adipotide?\u00a0<\/b><\/h2>\n
Common Dosing Protocols for Adipotide In-Vitro Research Setting\u00a0<\/b><\/h2>\n
FAQs<\/b><\/h2>\n
Scientific References<\/b><\/em><\/h2>\n
\n